Literature DB >> 16374819

An association between type 1 diabetes and idiopathic generalized epilepsy.

Dougall McCorry1, A Nicolson, D Smith, A Marson, Richard G Feltbower, D W Chadwick.   

Abstract

OBJECTIVE: Idiopathic generalized epilepsies (IGEs) account for approximately 30% of all patients with epilepsy. Both the IGEs and type 1 diabetes mellitus (T1D) represent serious worldwide problems, because of related medical and social management costs. Clinical experience suggested the two conditions were seen in individuals more frequently than might be expected by chance.
METHODS: We compared the population prevalence of T1D in 15- to 30-year-olds to a cohort of 518 15- to 30-year-olds with IGE.
RESULTS: We found a highly significant excess of T1D in our IGE cohort, with an odds ratio of 4.4 (95% confidence interval, 2.1-9.2).
INTERPRETATION: Our results suggest that the prevalence of T1D is increased by a factor of four in young adults with IGE. To our knowledge, this is the first published association between the two conditions and expands the diseases known to be associated with T1D.

Entities:  

Mesh:

Year:  2006        PMID: 16374819     DOI: 10.1002/ana.20727

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

1.  Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.

Authors:  Esther Ganelin-Cohen; Dalit Modan-Moses; Rina Hemi; Hannah Kanety; Bruria Ben-Zeev; Christiane S Hampe
Journal:  Pediatr Diabetes       Date:  2015-12-29       Impact factor: 4.866

Review 2.  Diabetes and epilepsy in children and adolescents.

Authors:  M Loredana Marcovecchio; Marianna Immacolata Petrosino; Francesco Chiarelli
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

3.  The intriguing relationship between epilepsy and type 1 diabetes mellitus.

Authors:  Josemir W Sander; Jan Novy; Mark R Keezer
Journal:  Diabetologia       Date:  2016-05-18       Impact factor: 10.122

Review 4.  Blood Brain Barrier Injury in Diabetes: Unrecognized Effects on Brain and Cognition.

Authors:  Marina Bogush; Nathan A Heldt; Yuri Persidsky
Journal:  J Neuroimmune Pharmacol       Date:  2017-05-29       Impact factor: 4.147

5.  Reactions of the immune system in epilepsy.

Authors:  Inimioara Mihaela Cojocaru; Manole Cojocaru
Journal:  Maedica (Buchar)       Date:  2010-07

6.  Risk of epilepsy in type 1 diabetes mellitus: a population-based cohort study.

Authors:  I-Ching Chou; Chung-Hsing Wang; Wei-De Lin; Fuu-Jen Tsai; Che-Chen Lin; Chia-Hung Kao
Journal:  Diabetologia       Date:  2016-03-31       Impact factor: 10.122

7.  Quantification of diabetes comorbidity risks across life using nation-wide big claims data.

Authors:  Peter Klimek; Alexandra Kautzky-Willer; Anna Chmiel; Irmgard Schiller-Frühwirth; Stefan Thurner
Journal:  PLoS Comput Biol       Date:  2015-04-09       Impact factor: 4.475

8.  Evaluation of Anticonvulsive Effect of Magnesium Oxide Nanoparticles in Comparison with Conventional MgO in Diabetic and Non-diabetic Male Mice.

Authors:  Leila Jahangiri; Mahnaz Kesmati; H Najafzadeh
Journal:  Basic Clin Neurosci       Date:  2014

9.  Epileptogenicity of diabetes and antiepileptogenicity of ketogenic states: Clarity or confusion?

Authors:  Sanjay Kalra; A G Unnikrishnan; Yashdeep Gupta
Journal:  Indian J Endocrinol Metab       Date:  2016 Sep-Oct

10.  The effects of glycemic control on seizures and seizure-induced excitotoxic cell death.

Authors:  Paula Elyse Schauwecker
Journal:  BMC Neurosci       Date:  2012-08-06       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.